|
業務類別
|
-- |
|
業務概覽
|
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%). The Americas account for the largest portion of the firm's revenue (40%), followed by Asia-Pacific (27%) and Europe, the Middle East, and Africa (27%). BioMerieux is headquartered in Marcy-l'Etoile, France. |
| 公司地址
| Marcy l’Etoile, Lyon, FRA, 69280 |
| 電話號碼
| +33 478872000 |
| 傳真號碼
| +33 478872090 |
| 公司網頁
| https://www.biomerieux.com |
| 員工數量
| 15226 |
| Mr. Alexandre Merieux |
Chairman of the Board and Chief Executive Officer |
-- |
17/03/2026 |
|
|
| Mr. Jean-Luc Belingard |
Director |
17/03/2026 |
| Mr. Francois Lacoste |
Director |
17/03/2026 |
| Mr. Harold Y H Boel |
Independent Director |
17/03/2026 |
| Dr. Philippe Archinard |
Director |
17/03/2026 |
| Ms. Marie-Helene Habert-Dassault |
Independent Director |
17/03/2026 |
| Ms. Fanny Letier |
Independent Director |
17/03/2026 |
| Ms. Viviane Monges |
Independent Director |
17/03/2026 |
| Mr. Alexandre Merieux |
Chairman of the Board and Chief Executive Officer |
17/03/2026 |
| Mr. Sylvain Orenga |
Director |
17/03/2026 |
| Ms. Marie-Paule Kieny |
Independent Director |
17/03/2026 |
|
|
|
|
